Cytokines and chemokines skin gene expression in correlation with immune cells in blood and severity in equine insect bite hypersensitivity.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 09 04 2024
accepted: 26 06 2024
medline: 30 7 2024
pubmed: 30 7 2024
entrez: 30 7 2024
Statut: epublish

Résumé

Insect bite hypersensitivity (IBH) is the most frequent skin allergy of horses and is highly debilitating, especially in the chronic phase. IBH is caused by IgE-mediated hypersensitivity reactions to culicoides midge bites and an imbalanced immune response that reduces the welfare of affected horses. In the present study, we investigated the pathological mechanisms of IBH, aiming to understand the immune cell modulation in acute allergic skin lesions of IBH horses with the goal of finding possible biomarkers for a diagnostic approach to monitor treatment success. By qPCR, we quantified the gene expression of cytokines, chemokines, and immune receptors in skin punch biopsies of IBH with different severity levels and healthy horses simultaneously in tandem with the analysis of immune cell counts in the blood. Our data show an increase in blood eosinophils, monocytes, and basophils with a concomitant, significant increase in associated cytokine, chemokine, and immune cell receptor mRNA expression levels in the lesional skin of IBH horses. Moreover, IL-5Ra, CCR5, IFN-γ, and IL-31Ra were strongly associated with IBH severity, while IL-31 and IL-33 were rather associated with a milder form of IBH. In addition, our data show a strong correlation of basophil cell count in blood with IL-31Ra, IL-5, IL-5Ra, IFN-γ, HRH2, HRH4, CCR3, CCR5, IL-12b, IL-10, IL-1β, and CCL26 mRNA expression in skin punch biopsies of IBH horses. In summary, several cytokines and chemokines have been found to be associated with disease severity, hence contributing to IBH pathology. These molecules can be used as potential biomarkers to monitor the onset and progression of the disease or even to evaluate and monitor the efficacy of new therapeutic treatments for IBH skin allergy. To our knowledge, this is the first study that investigated immune cells together with a large set of genes related to their biological function, including correlation to disease severity, in a large cohort of healthy and IBH horses.

Sections du résumé

Background UNASSIGNED
Insect bite hypersensitivity (IBH) is the most frequent skin allergy of horses and is highly debilitating, especially in the chronic phase. IBH is caused by IgE-mediated hypersensitivity reactions to culicoides midge bites and an imbalanced immune response that reduces the welfare of affected horses.
Objective UNASSIGNED
In the present study, we investigated the pathological mechanisms of IBH, aiming to understand the immune cell modulation in acute allergic skin lesions of IBH horses with the goal of finding possible biomarkers for a diagnostic approach to monitor treatment success.
Methods UNASSIGNED
By qPCR, we quantified the gene expression of cytokines, chemokines, and immune receptors in skin punch biopsies of IBH with different severity levels and healthy horses simultaneously in tandem with the analysis of immune cell counts in the blood.
Results UNASSIGNED
Our data show an increase in blood eosinophils, monocytes, and basophils with a concomitant, significant increase in associated cytokine, chemokine, and immune cell receptor mRNA expression levels in the lesional skin of IBH horses. Moreover, IL-5Ra, CCR5, IFN-γ, and IL-31Ra were strongly associated with IBH severity, while IL-31 and IL-33 were rather associated with a milder form of IBH. In addition, our data show a strong correlation of basophil cell count in blood with IL-31Ra, IL-5, IL-5Ra, IFN-γ, HRH2, HRH4, CCR3, CCR5, IL-12b, IL-10, IL-1β, and CCL26 mRNA expression in skin punch biopsies of IBH horses.
Conclusion UNASSIGNED
In summary, several cytokines and chemokines have been found to be associated with disease severity, hence contributing to IBH pathology. These molecules can be used as potential biomarkers to monitor the onset and progression of the disease or even to evaluate and monitor the efficacy of new therapeutic treatments for IBH skin allergy. To our knowledge, this is the first study that investigated immune cells together with a large set of genes related to their biological function, including correlation to disease severity, in a large cohort of healthy and IBH horses.

Identifiants

pubmed: 39076967
doi: 10.3389/fimmu.2024.1414891
pmc: PMC11284025
doi:

Substances chimiques

Cytokines 0
Chemokines 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1414891

Informations de copyright

Copyright © 2024 Jebbawi, Chemnitzer, Dietrich, Pantelyushin, Lam, Rhiner, Keller, Waldern, Canonica and Fettelschoss-Gabriel.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Fadi Jebbawi (F)

Department of Dermatology, University Hospital Zurich, Schlieren, Switzerland.
Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Evax AG, Guntershausen, Switzerland.

Alex Chemnitzer (A)

Department of Dermatology, University Hospital Zurich, Schlieren, Switzerland.
Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Evax AG, Guntershausen, Switzerland.

Macsmeila Dietrich (M)

Department of Dermatology, University Hospital Zurich, Schlieren, Switzerland.

Stanislav Pantelyushin (S)

Department of Dermatology, University Hospital Zurich, Schlieren, Switzerland.
Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Evax AG, Guntershausen, Switzerland.

Juwela Lam (J)

Department of Dermatology, University Hospital Zurich, Schlieren, Switzerland.
Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Evax AG, Guntershausen, Switzerland.

Tanya Rhiner (T)

Evax AG, Guntershausen, Switzerland.
Equine Department, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.

Giulia Keller (G)

Department of Dermatology, University Hospital Zurich, Schlieren, Switzerland.
Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Evax AG, Guntershausen, Switzerland.

Nina Waldern (N)

Evax AG, Guntershausen, Switzerland.

Fabia Canonica (F)

Department of Dermatology, University Hospital Zurich, Schlieren, Switzerland.
Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Evax AG, Guntershausen, Switzerland.

Antonia Fettelschoss-Gabriel (A)

Department of Dermatology, University Hospital Zurich, Schlieren, Switzerland.
Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Evax AG, Guntershausen, Switzerland.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH